Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1994-09-26
1996-07-30
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 31195
Patent
active
055412262
ABSTRACT:
Persistent epithelial defects are effectively treated by topically applying a gelatinous composition containing either aminocaproic acid or tranexamic acid to the eye. In vivo results demonstrate improved healing of the epithelium and basement membrane complex. The gelatinous composition is prepared by a process that ensures sterility and proper pH conditions throughout the gel.
REFERENCES:
patent: 4171377 (1979-10-01), Green et al.
Moses et al; 1985, Ann Ophtamol, vol. 17 (11) pp. 714-716 (Abstract).
Rond et al 109CA:236901q 1988.
R. R. Allingham et al., "Topical Aminocaproic Acid Significantly Reduces the Incidence of Secondary Hemorrhage in Traumatic Hyphema in the Rabbit Model," Laboratory Sciences, 106, 1436-1438 (Oct. 1988).
H. E. Kaufman et al., eds., The Cornea, Churchill Livingstone, "Corneal Trauma," pp. 619-621 (1988).
H. M. Leibowitz, ed., Corneal Disorders, Clinical Diagnosis and Management, W. B. Saunders Company, pp. 222-227 (1984).
W. Tasman et al., ed., Duane's Clinical Ophthalmology, J. B. Lippincott Company, pp. 1-22, Revised Edition (1993).
Robert C. Arffa; "Epithelial Diseases, Chapter 15;" Grayson's Diseases of the Cornea; Kimberly Kist, ed.; 324-332 (1991).
Ramon R. Berrios et al., "Traumatic Hyphemia," International Ophthalmology Clinics, Trauma, 35, 93-103 (1995).
Alvina M. Janda, "Ocular Trauma--Triage and Treatment," Postgraduate Medicine, 90, 51-52, 55-57, 59-60 (Nov. 15, 1991).
Bradford Shingleton, "Eye Injuries," The New England Journal of Medicine, 325, 408-413 (Aug. 8, 1991).
M. Verstraete, "Clinical Application of Inhibitors of Fibrinolysis," Drugs--Focus on Flecainide and Terfenadine--Multiple Sclerosis Diuretics: A Review, 29 236-261 (Jan. 1985).
Crouch Earl R.
Williams Patricia B.
Center For Innovative Technology
Travers Russell
LandOfFree
Topical compositions for re-epithelialization of persistent epit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical compositions for re-epithelialization of persistent epit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical compositions for re-epithelialization of persistent epit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1659076